Price (delayed)
$0.9081
Market cap
$15.43M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.6
Enterprise value
$8.54M
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known
There are no recent dividends present for TLPH.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.